智通财经APP讯，白云山(00874)发布公告，该公司附属广州医药于2025年4月29日收到全国股转公司出具的《关于同意广州医药股份有限公司股票公开转让并在全国股转系统挂牌的函》，同意广州医药股票公开转让并在全国中小企业股份转让系统挂牌，交易方式为集合竞价交易。广州医药申请公开转让并挂牌时股东人数未超过200人，按规定中国证监会豁免注册，广州医药挂牌后纳入非上市公众公司监管。广州医药将按照有关规定办理挂牌、报备等手续。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.